Johnson & Johnson General Corporate — Total Assets increased by 5.6% to $36.60B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.6%, from $49.83B to $36.60B.
An increase may indicate higher corporate cash reserves or centralized investments, while a decrease could signal capital deployment or asset divestiture.
This represents the total value of assets held at the corporate level that are not specifically allocated to individual...
Most large-cap conglomerates report similar unallocated corporate assets, often representing the company's central treasury and non-operational holdings.
jnj_segment_general_corporate_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $39.19B | $30.75B | $34.52B | $38.71B | $49.83B | $31.16B | $31.89B | $34.67B | $36.60B |
| QoQ Change | — | -21.5% | +12.3% | +12.1% | +28.7% | -37.5% | +2.4% | +8.7% | +5.6% |
| YoY Change | — | -21.5% | +12.3% | +12.1% | — | — | — | -10.4% | -26.6% |